Islets of Hope diabetes headline news

islets of hope home buttondiabetes law buttonchildren with diabetes, right to educationclincal trials, research, studies buttondiabetes type 1 and type 2 support groups type 1 diabetes informationtype 2 diabetes information

diabetes news headlines and research                            Drug & Medical Procedures


FDA, UK & European Drug & Medical Updates/Approvals/Recalls/Warnings

If you copy our list of links for your own site, we'd really appreciate it if you would add a link to our site as well.  Your support and mention of www.IsletsofHope.com will help others with diabetes.  We now donate 100% of the profits from our website to nonprofit diabetes organizations that purchase insulin, diabetes medications, and supplies for others in need.

|  Business  | Diabetes Events | Drug Research & Development   Education  | General Diabetes Studies   Human Interest  |
|  
Legislation - Diabetes, Ethics, Research  | Stem Cell Research  | Your Diabetes Health | Technology (Diabetes)  |
 FDA, UK & European Drug & Medical Updates Approvals/Rejections/Warnings
RECALLS & WARNINGS for Diabetes Medications, Products & Devices  |


November 2006

See "Current Headlines"


October 2006

Back to Top


September 2006

Back to Top


August 2006

Back to Top


July 2006

Back to Top


June 2006

  • Merck & Co: planning to reap sweet rewards in diabetes - Merck & Co has revealed plans to file for FDA approval of MK-0431A in 2006, potentially enabling it to overtake Novartis in the race to commercialize the first DPP-4 inhibitor. The news is also of particular significance to Mercks diabetes pipeline following its failure to successfully launch a drug in the dual PPAR class.  06/08/2006
  • MediaFact Launches Section On Zyprexa and Diabetes - MediaFact (http://www.mediafact.com), an online resource for information on health care issues related to hazardous occupational exposure and drug side effects, has published a new section on Zyprexa and diabetes. Zyprexa (olanzapine), manufactured by Eli Lilly and Company, is a widely prescribed antipsychotic drug used for the treatment of schizophrenia and manic depression. Evidence now suggests that Zyprexa is linked to the development of diabetes in a significant number of patients. 06/08/2006
  • Warning over faulty diabetes aid - BBC News - Regulators warn diabetes patients a fault in vital equipment could put them at risk of an overdoes of insulin.  06/08/2006
  • (AFX UK Focus) 2006-06-05 14:58 GMT: Merck to file Januvia diabetes type II drug in 2006; earlier than expected - Merck & Co Inc said it expects to file a new drug application for its type 2 diabetes drug Januvia to the Food and Drug Administration in 2006, earlier than its initially anticipated 2007 date.  06/05/2006

Back to Top


May 2006

Back to Top


April 2006

Back to Top


March 2006

Back to Top


February 2006

Back to Top


January 2006

Back to Top


December 2005

Back to Top


November 2005 - November is National Diabetes Month

Back to Top


October 2005

Back to Top


September 2005

Back to Top


August 2005

Back to Top


Diabetes Headline News Resources

Back to Top

|  Contact Us  |  About IOH  |  Our Mission  |  Elizabeth's Story  |  About the Founder  |  Join IOH  |  How To Help  |  Advertise  |  Privacy Statement |  Site Index  |

Page Updated 11/01/2006